182 related articles for article (PubMed ID: 18698578)
21. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
[TBL] [Abstract][Full Text] [Related]
22. Uncoupling protein-2 and non-alcoholic fatty liver disease.
Baffy G
Front Biosci; 2005 Sep; 10():2082-96. PubMed ID: 15970480
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial dysfunction in nonalcoholic steatohepatitis.
Serviddio G; Bellanti F; Vendemiale G; Altomare E
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):233-44. PubMed ID: 21476918
[TBL] [Abstract][Full Text] [Related]
24. Targeted expression of uncoupling protein 2 to mouse liver increases the susceptibility to lipopolysaccharide/galactosamine-induced acute liver injury.
Shang Y; Liu Y; Du L; Wang Y; Cheng X; Xiao W; Wang X; Jin H; Yang X; Liu S; Chen Q
Hepatology; 2009 Oct; 50(4):1204-16. PubMed ID: 19637283
[TBL] [Abstract][Full Text] [Related]
25. Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.
Xu H; Hertzel AV; Steen KA; Wang Q; Suttles J; Bernlohr DA
Mol Cell Biol; 2015 Mar; 35(6):1055-65. PubMed ID: 25582199
[TBL] [Abstract][Full Text] [Related]
26. Role of age and uncoupling protein-2 in oxidative stress, RAGE/AGE interaction and inflammatory liver injury.
Kuhla A; Trieglaff C; Vollmar B
Exp Gerontol; 2011 Nov; 46(11):868-76. PubMed ID: 21820503
[TBL] [Abstract][Full Text] [Related]
27. Antioxidant activity by a synergy of redox-sensitive mitochondrial phospholipase A2 and uncoupling protein-2 in lung and spleen.
Jabůrek M; Ježek J; Zelenka J; Ježek P
Int J Biochem Cell Biol; 2013 Apr; 45(4):816-25. PubMed ID: 23354121
[TBL] [Abstract][Full Text] [Related]
28. Endothelial uncoupling protein 2 regulates mitophagy and pulmonary hypertension during intermittent hypoxia.
Haslip M; Dostanic I; Huang Y; Zhang Y; Russell KS; Jurczak MJ; Mannam P; Giordano F; Erzurum SC; Lee PJ
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1166-78. PubMed ID: 25814675
[TBL] [Abstract][Full Text] [Related]
29. Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice.
Hong J; Jia Y; Pan S; Jia L; Li H; Han Z; Cai D; Zhao R
Oncotarget; 2016 Aug; 7(35):56071-56082. PubMed ID: 27528227
[TBL] [Abstract][Full Text] [Related]
30. Contribution of endogenous inhibitor of nitric oxide synthase to hepatic mitochondrial dysfunction in streptozotocin-induced diabetic rats.
Chen N; Leng YP; Xu WJ; Luo JD; Chen MS; Xiong Y
Cell Physiol Biochem; 2011; 27(3-4):341-52. PubMed ID: 21471723
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver.
Rashid A; Wu TC; Huang CC; Chen CH; Lin HZ; Yang SQ; Lee FY; Diehl AM
Hepatology; 1999 Apr; 29(4):1131-8. PubMed ID: 10094957
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of uncoupling protein 2 mRNA in genetic obesity: lack of an essential role for leptin, hyperphagia, increased tissue lipid content, and TNF-alpha.
Memon RA; Hotamisligil GS; Wiesbrock SM; Uysal KT; Faggioni R; Moser AH; Feingold KR; Grunfeld C
Biochim Biophys Acta; 2000 Feb; 1484(1):41-50. PubMed ID: 10685029
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.
Poulsen MM; Larsen JØ; Hamilton-Dutoit S; Clasen BF; Jessen N; Paulsen SK; Kjær TN; Richelsen B; Pedersen SB
Nutr Res; 2012 Sep; 32(9):701-8. PubMed ID: 23084643
[TBL] [Abstract][Full Text] [Related]
34. Role of mitochondria in non-alcoholic fatty liver disease.
Pessayre D
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S20-7. PubMed ID: 17567459
[TBL] [Abstract][Full Text] [Related]
35. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
[TBL] [Abstract][Full Text] [Related]
36. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
[TBL] [Abstract][Full Text] [Related]
37. Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway.
Zhou L; Yu X; Meng Q; Li H; Niu C; Jiang Y; Cai Y; Li M; Li Q; An C; Shu L; Chen A; Su H; Tang Y; Yin S; Raschke S; Eckardt K; Eckel J; Yang Z
Hepatology; 2013 Apr; 57(4):1384-93. PubMed ID: 23174781
[TBL] [Abstract][Full Text] [Related]
38. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
39. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.
Verbeek J; Lannoo M; Pirinen E; Ryu D; Spincemaille P; Vander Elst I; Windmolders P; Thevissen K; Cammue BP; van Pelt J; Fransis S; Van Eyken P; Ceuterick-De Groote C; Van Veldhoven PP; Bedossa P; Nevens F; Auwerx J; Cassiman D
Gut; 2015 Apr; 64(4):673-83. PubMed ID: 24917551
[TBL] [Abstract][Full Text] [Related]
40. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
